Peter Lamb - Nov 15, 2022 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
EVP, Scientific Strategy & CSO
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Nov 15, 2022
Transactions value $
-$119,928
Form type
4
Date filed
11/17/2022, 07:42 PM
Previous filing
Aug 5, 2022
Next filing
Dec 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Tax liability -$120K -7.18K -1.72% $16.71 411K Nov 15, 2022 Direct F1, F2
holding EXEL Common Stock 17.1K Nov 15, 2022 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 11, 2020, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on September 30, 2021.
F2 Includes 120,383 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F3 Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 14, 2022.